mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.02 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.02 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.03 |